Current Neuropharmacology logo Bentham Science Publishers logo

Current Neuropharmacology aims to provide current, timely and comprehensive reviews of all areas of neuropharmacology and related matters of neuroscience. The journal publishes reviews written by experts and leaders in the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience. The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.

Publisher: Bentham Science Publishers

Volume 3, Number 1, January 2005
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Book review

Review article

Partial Dopamine Agonists and the Treatment of Psychosis
pp. 3-8(6)
Author: Carol A. Tamminga

Novel Potential Therapeutics for Schizophrenia: Focus on the Modulation of Metabotropic Glutamate Receptor Function
pp. 9-34(26)
Authors: Laura E. Chavez-Noriega; Michael J. Marino; Herve Schaffhauser; Una C. Campbell; P. J. Conn

GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia
pp. 45-62(18)
Authors: David W. Volk; David A. Lewis

Gender Differences in Pharmacokinetics and Side Effects of Second Generation Antipsychotic Drugs
pp. 73-85(13)
Authors: W. Aichhorn; M. Gasser; E. M. Weiss; C. Adlassnig; J. Marksteiner

Addendum

Author Index to Volume 2
pp. 87-87(1)
Author: Bentham Science Publishers

Subject Index to Volume 2
pp. 89-93(5)
Author: Bentham Science Publishers

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A